These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2393351)

  • 1. [An anti-human eosinophil monoclonal antibody AE500 that reacts only with granulocytes from hypereosinophilic patients].
    Ochiai K; Iwamoto I; Kimura A; Nakagawa N; Tomioka H; Yoshida S; Takahashi H; Yoshida A
    Arerugi; 1990 May; 39(5):459-64. PubMed ID: 2393351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of an anti-eosinophil monoclonal antibody that recognizes granulocytes from patients with blood eosinophilia but not from subjects without eosinophilia.
    Ochiai K; Iwamoto I; Takahashi H; Yoshida S; Nakagawa N; Tomioka H; Yoshida S
    Clin Exp Immunol; 1991 May; 84(2):283-8. PubMed ID: 2025954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma membrane antigens on light density and activated human blood eosinophils.
    Tai PC; Bakes DM; Barkans JR; Spry CJ
    Clin Exp Immunol; 1985 May; 60(2):427-36. PubMed ID: 4006306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
    Heinisch IV; Bizer C; Volgger W; Simon HU
    J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700.
    Kim YJ; Prussin C; Martin B; Law MA; Haverty TP; Nutman TB; Klion AD
    J Allergy Clin Immunol; 2004 Dec; 114(6):1449-55. PubMed ID: 15577851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to human eosinophil plasma membrane antigens enhance the secretion of eosinophil cationic protein.
    Tai PC; Capron M; Bakes DM; Barkans J; Spry CJ
    Clin Exp Immunol; 1986 Mar; 63(3):728-37. PubMed ID: 3708911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of lacto-N-fucopentaose III (CD15)- and sialyl-Lewis X-bearing molecules and their functional properties in eosinophils from patients with the idiopathic hypereosinophilic syndrome.
    Satoh T; Knowles A; Li MS; Sun L; Tooze JA; Zabucchi G; Spry CJ
    Immunology; 1994 Oct; 83(2):313-8. PubMed ID: 7835953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of activated Fc gamma RII discriminates between multiple granulocyte-priming phenotypes in peripheral blood of allergic asthmatic subjects.
    Kanters D; ten Hove W; Luijk B; van Aalst C; Schweizer RC; Lammers JW; Leufkens HG; Raaijmakers JA; Bracke M; Koenderman L
    J Allergy Clin Immunol; 2007 Nov; 120(5):1073-81. PubMed ID: 17697704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of CD69 expression on peripheral eosinophils in episodic angioedema and eosinophilia.
    Kawano M; Muramoto H; Tsunoda S; Koni I; Mabuchi H; Yachie A; Miyawaki T
    Am J Hematol; 1996 Sep; 53(1):43-5. PubMed ID: 8813097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis.
    Stein ML; Collins MH; Villanueva JM; Kushner JP; Putnam PE; Buckmeier BK; Filipovich AH; Assa'ad AH; Rothenberg ME
    J Allergy Clin Immunol; 2006 Dec; 118(6):1312-9. PubMed ID: 17157662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis.
    Nakamura A; Yamazaki K; Suzuki K; Sato S
    Am J Gastroenterol; 1997 Dec; 92(12):2245-9. PubMed ID: 9399763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophil membrane antigens: phenotypic frequencies in normal individuals and patients with the hypereosinophilic syndrome.
    Tai PC; Spry CJ; Bakes DM; Barkans JR
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):249-51. PubMed ID: 4008080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354).
    Blanchard C; Mishra A; Saito-Akei H; Monk P; Anderson I; Rothenberg ME
    Clin Exp Allergy; 2005 Aug; 35(8):1096-103. PubMed ID: 16120093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilia in children. Cytochemical and immunological analysis of increased eosinophils.
    Ishii E; Mizuno Y; Hara T; Okamura J; Aoki T; Kanehara Y; Suda M; Takeshita M; Kikuchi M; Ueda K
    Am J Pediatr Hematol Oncol; 1987; 9(4):308-13. PubMed ID: 3439581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive effect of eosinophilia and atopy on exhaled nitric oxide levels in children with or without a history of respiratory symptoms.
    Barreto M; Villa MP; Monti F; Bohmerova Z; Martella S; Montesano M; Darder MT; Ronchetti R
    Pediatr Allergy Immunol; 2005 Feb; 16(1):52-8. PubMed ID: 15693912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is a single blood eosinophil count a reliable marker for "eosinophilic asthma?".
    Spector SL; Tan RA
    J Asthma; 2012 Oct; 49(8):807-10. PubMed ID: 22900679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.
    Hart TK; Cook RM; Zia-Amirhosseini P; Minthorn E; Sellers TS; Maleeff BE; Eustis S; Schwartz LW; Tsui P; Appelbaum ER; Martin EC; Bugelski PJ; Herzyk DJ
    J Allergy Clin Immunol; 2001 Aug; 108(2):250-7. PubMed ID: 11496242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of factors chemotactic for granulocytes in hypereosinophilic syndrome sera: relation with alterations in eosinophil migration.
    Gosset P; Prin L; Capron M; Auriault C; Tonnel AB; Capron A
    Clin Exp Immunol; 1986 Sep; 65(3):654-63. PubMed ID: 3780047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and selective induction of blood eosinophilia in guinea pigs by recombinant human interleukin 5.
    Portanova JP; Christine LJ; Rangwala SH; Compton RP; Hirsch JL; Smith WG; Monahan JB
    Cytokine; 1995 Nov; 7(8):775-83. PubMed ID: 8664444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.